Clinical trial
Optivate in People With Von Willebrand Disease Undergoing Surgery
NCT00404300 · Bio Products Laboratory, Other · Terminated
Key facts
| NCT number | NCT00404300 |
|---|---|
| Title | Optivate in People With Von Willebrand Disease Undergoing Surgery |
| Official title | An Open Multi-centre Study to Investigate the Safety and Efficacy of OPTIVATE®, a High Purity, Dual Inactivated Factor VIII and Von Willebrand Factor Concentrate, in Patients With Von Willebrand Disease Who Are Undergoing Surgery |
| Lead sponsor | Bio Products Laboratory, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Von Willebrand Disease |
| Intervention type | Drug |
| Interventions | Optivate |
| Enrollment | 25 |
| Start date | Feb 1, 2007 |
| Completion | Sep 1, 2008 |
| First posted | Nov 28, 2006 |
| Last update posted | Mar 3, 2010 |
| Countries | Israel, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: